药金灵
Published by:
Sichuan Amofeng Pharmaceutical Co.LTD
Description
药金灵是四川阿莫锋药业有限公司旗下取得合法资质的B2B电子商务采购平台，致力于为零售终端（药店、诊所）打造一站式便携网络采购服务。依靠公司行业实力和互联网技术的不断创新，逐步形成医药流通环节信息流、物流、资金流的高度整合型平台。公司始终坚持以“规范经营、诚信第一、客户至上、服务第一”为宗旨。让医药采购不再琐碎，让成本一降再降。我们的APP区别传统采购的复杂繁琐模式，致力于打造一个“省时”省事”“省钱”的智能化平台。
Screenshots
药金灵 FAQ
-
Is 药金灵 free?
Yes, 药金灵 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 药金灵 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 药金灵 cost?
药金灵 is free.
-
What is 药金灵 revenue?
To get estimated revenue of 药金灵 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Switzerland yet.
Ratings History
药金灵 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
药金灵 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
药品终端网
选好品种，就用药品终端网
|
Unlock
|
Unlock
|
0
|
|
5 months ago | |
诊宝倍
让诊所升级为小三甲。
|
Unlock
|
Unlock
|
0
|
|
9 months ago | |
葵花药直达
|
Unlock
|
Unlock
|
0
|
|
2 months ago | |
3A医药城
|
Unlock
|
Unlock
|
0
|
|
6 months ago | |
华药师
华药师
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
华杰全优采
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
药聚合
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
荃豆中药
十万基层中医选择的专业中药饮片采购平台
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
药商通商城
|
Unlock
|
Unlock
|
0
|
|
3 months ago | |
采立惠
|
Unlock
|
Unlock
|
0
|
|
1 year ago |
药金灵 Installs
Last 30 days
药金灵 Revenue
Last 30 days药金灵 Revenue and Downloads
Gain valuable insights into 药金灵 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Health Fitness
- Publisher
- Sichuan Amofeng Pharmaceutical Co.LTD
- Languages
- English, Chinese
- Recent release
- 2.1.15 (6 months ago )
- Released on
- Dec 22, 2021 (3 years ago )
- Also available in
- China , Poland , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.